Val Sudakin, PhD, Senior Vice President, Head of Scientific Services at Connexion Healthcare, has been selected by PharmaVOICE as one of 2017’s “100 Most Inspiring People” in the life-sciences industry.
Dr. Sudakin is responsible for overseeing all scientific strategy and medical content at Connexion’s two Centers of Excellence, Oncology and Rare Disease, which span a range of disease states and therapeutic areas. He uses his scientific training in molecular biology through the postdoctoral level to effectively manage a wide range of competencies in a constantly evolving pharmaceutical/ biotechnology landscape. According to his colleagues, he shines as a selfless leader who has professional grace and integrity. He leads the oncology and rare teams at Connexion and collaborates with clients to help deliver therapeutics that provide meaningful advances to patients with cancer and rare diseases.
One colleague commented that “Val has a rare combination of scientific acumen and industry insight that assists in the growth and development of individuals at all levels of the company; at the same time, he promotes the future success of clients, with the ultimate goal of bringing therapies to market to enhance patients’ quality of life.”
According to his peers in industry, Dr. Sudakin has a unique, nuanced understanding of the pharmaceutical landscape and how medical communications professionals can serve as true strategic partners to their clients. He is widely admired and respected in the industry. To a great extent, his leadership has been a key driver behind long and successful professional relationships. According to one long-term client, “Val’s attention to detail, insight, and patience result in superior deliverables. He has been instrumental in the successful implementation of multiple projects that span the entire product life cycle.”
Dr. Sudakin is being recognized because of his overall passion, conviction, and inspirational qualities; his ability to turn obstacles into opportunities and to develop innovative strategies, products, and services; his willingness to mentor and guide the next generation of industry leaders; his skill at finding new paths and lifting Connexion to new heights; and his dedication to improving the lives of patients.
Dr. Sudakin will be honored at the third annual PharmaVOICE 100 Celebration on September 14, 2017, in New York City. The annual PharmaVOICE 100 issue, July/August, will showcase Dr. Sudakin along with the other distinguished executives.
About Connexion Healthcare:
Connexion Healthcare is a full-service medical communications company established in 1999 with locations in Newtown, PA, and Cambridge, MA. Connexion partners with large and small pharmaceutical and biotech companies.
For further information regarding the Oncology Center of Excellence at Connexion Healthcare and how we can develop oncology communications to differentiate therapies by their unique attributes, contact: